AI-generated analysis. Always verify with the original filing.
Incyte Corporation announced title changes for three executives effective March 25, 2026: Pablo J. Cagnoni to President, Incyte and Global Head of Research and Development, replacing William J. Meury as President; Steven H. Stein to Executive Vice President, Chief Medical Officer and Head of Late-stage Development; and Mohamed Issa to Executive Vice President and Head of U.S. Commercial. No changes to compensation arrangements; Matteo Trotta will leave following a transition period.
Event Type
Disclosure
Mandatory
Variant
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On March 25,
Financial Statements and Exhibits (d) Exhibits Exhibits Description 99.1 Press release issued by Incyte Corporation dated March 25, 2026. 104 Cover Page Interac
Pablo J. Cagnoni
Effective: 2026-03-25
Replaces William J. Meury as President, Incyte
Steven H. Stein
Effective: 2026-03-25
Mohamed Issa
Effective: 2026-03-25
William J. Meury
Effective: 2026-03-25
Matteo Trotta
Effective: Following transition period
Part of transition